(r)4-bromo-n-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide

⇄

cholecystokinin B receptor ; Rattus norvegicus







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 21493750 JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability. 2011 Jul 1